Compare SERA & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SERA | JRVR |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.5M | 288.2M |
| IPO Year | 2021 | 2014 |
| Metric | SERA | JRVR |
|---|---|---|
| Price | $2.13 | $6.32 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.33 |
| AVG Volume (30 Days) | 59.5K | ★ 225.9K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | 32.32 | ★ 125.82 |
| EPS | N/A | ★ 0.79 |
| Revenue | $81,000.00 | ★ $687,614,000.00 |
| Revenue This Year | $554.81 | N/A |
| Revenue Next Year | $517.27 | $1.61 |
| P/E Ratio | ★ N/A | $7.85 |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.37 | $4.10 |
| 52 Week High | $4.09 | $7.20 |
| Indicator | SERA | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 49.50 |
| Support Level | $1.72 | $6.15 |
| Resistance Level | $3.59 | $6.39 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 57.00 | 83.33 |
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.